CSPC Pharmaceutical starts Phase I trial for SYH2056 tablets in China
CSPC Pharmaceutical Group Limited has initiated a Phase I clinical trial in China of SYH2056 tablets.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.